About BioAge Labs, Inc.
BioAge is a clinical-stage biotechnology company that focuses on harnessing the biology of human aging. The company develops novel targets and therapies for metabolic diseases. Their proprietary platform provides unique biological insights and druggable mechanisms for age-related disease. BioAge's preclinical programs address key pathways in metabolic aging, leveraging insights from their discovery platform built on human longevity data. Their lead program, azelaprag, is a potential first and best-in-class oral weight loss therapy, co-administered with incretin drugs to achieve injectable-like total weight loss. BioAge's human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify molecular mediators of aging and disease. The company's pipeline programs target key pathways that drive metabolic aging based on insights from their platform.
BioAge Labs Stock Price
Trailing performance
Quarterly performance
BioAge Labs Valuation
BioAge Labs Funding
Capital structure
Internal marks
| Type | Valuation | Date | PPS | Source |
|---|---|---|---|---|
| 409-A | $lOOB | Jan 1, lOBB | $lO.OO | Source |
| 409-A | $lOOB | Jan 1, lOBB | $lO.OO | Source |
Frequently Asked Questions
Does BioAge Labs have stock?
Yes. BioAge Labs is a private venture-backed company. Investors usually purchase preferred stock and employees typically receive common stock options or restricted stock units (RSUs) as part of their compensation.
What is BioAge Labs's stock symbol?
Since it is not publicly listed, there is no BioAge Labs stock symbol or BioAge Labs ticker symbol assigned for BioAge Labs.
Private companies typically reserve a stock symbol up to two years prior to an IPO, and disclose this when they file a Form S-1 with the Security Exchange Commission when they start the IPO process.
How can I sell BioAge Labs stock?
If you own shares of a private company, it may be possible to find liquidity for your holdings before the company goes public. Finding the right private market broker can make all the difference as the best brokers can leverage deep industry relationships and negotiate on your behalf.
If you are interested in selling private stock you can reach out to Premier brokers for more information.
How do BioAge Labs pre-IPO trades work?
Private market transactions can be complex and may involve company approvals, legal purchase agreements and wires to third parties. Trades can take 30 - 60 days to complete which is why many investors work with experienced private market brokers to help guide the process.
Direct share transfers typically require issuer approvals. Issuers may exercise the right of first refusal (ROFR) in order to direct the seller to a buyer of their choosing.
Some issuers do not allow transactions. In these cases, buyers will need to purchase indirect interests in the business via special purpose vehicles (SPVs) or forward purchase contracts (forwards).
Is BioAge Labs publicly traded?
BioAge Labs stock does not trade publicly on Nasdaq or NYSE because it is still a private company. BioAge Labs stock might be available for purchase in the secondary markets, but BioAge Labs stock is not available for purchase by the general public, and can not be purchased through traditional brokerage accounts.
How can I buy BioAge Labs stock?
Only accredited investors and qualified purchasers can buy private stock. These investors buy pre-IPO stock in the secondary market from existing employees and investors.
To learn more about the market for BioAge Labs stock, talk to the best brokers on the planet.
How to invest in BioAge Labs?
Accredited investors can purchase shares in private companies like BioAge Labs. Investors can rely on Notice Premier Brokers to find supply and guide them through the trading process.
Because BioAge Labs is privately held, its stock is not available for purchase through public stock exchanges like the NYSE or Nasdaq. Retail investors can not access this stock via traditional brokerage accounts, and are not allowed to invest directly in BioAge Labs pre-IPO.
Popular companies
